Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 21, 2024
PCI Pharma Services has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus.
read more
Wednesday, January 06, 2021
Panthera’s clinical trial sites began dosing volunteers in the Phase III trial which will evaluate AstraZeneca’s long-acting antibody combination for the potential prevention of COVID-19.
read more
Monday, September 07, 2020
PAI announced the company has been awarded a three-year contract from HealthTrust Purchasing Group as a supplier of pharmaceutical products to its Membership nationwide.
read more
Tuesday, October 11, 2022
The Outsourcing Facilities Association (OFA) announced that it has reached a settlement agreement with the FDA that spurs the FDA to promptly review long-pending nominations for active pharmaceutical ingredients for use by FDA-registered outsourcing ...
read more
Orchard Therapeutics and MolMed have extended their collaboration – initiated in April 2018 – for a period of five years through June 2025.
read more
Orbit Discovery has announced the commencement of a partnership with WuXi AppTec, a global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry.
read more
Monday, November 23, 2020
Onyx Scientific announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license.
read more
Onyx Scientific has made a strategic investment to position the company for a commercial API license.
read more
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ...
read more
Olon S.p.A. announced the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
read more
Wednesday, January 24, 2018
Nutra Pharma is partnering with EuroAmerican IP to distribute their Over-the-Counter (OTC) pain reliever, Nyloxin Topical Gel.
read more
Tuesday, February 13, 2024
Catalent, Inc. and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, announced that they have entered into a merger agreement under which Novo Holdings will acquire ...
read more
Tuesday, November 10, 2020
Novasep is investing €6.5 million to expand capacity & increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site.
read more
Thursday, December 09, 2021
Novasep, a supplier of services and technologies for the life sciences industry, has announced a €6 million investment on its Chasse-sur-Rhône site, France (38). This investment will increase and modernize its manufacturing capabilities to support ...
read more
Novasep, a supplier of services and technologies for the life sciences industry, announced a €6.1 million investment at its Mourenx facility(Pyrénées-Atlantiques – France). This investment will modernize its API manufacturing facility.
read more